ATLAS fair value
ATLAS has no fair value for this stock today.
Boai NKY Pharmaceuticals stock price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · Shenzhen Stock Exchange · China
Prices as of Oct 27, 2026 · CNY
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Boai NKY Pharmaceuticals a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥9.77 and CN¥11.73; in 9 out of 10, between CN¥8.30 and CN¥13.81. Estimated annual volatility is 55%.
ATLAS does not publish a fair value for 300109.SHE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 300109.SHE has traded between CN¥10.57 and CN¥21.11. Today it is 49.0% below that high and 2% above its low.
On the business: net margin is 12.6%; it trades at 46.9 times earnings.
Its beta is 0.32: it tends to move less than the market.
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally.
Want to see everything about Boai NKY Pharmaceuticals?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally.
48%: close to a coin flip. In half of the simulated outcomes, 300109.SHE ends the month between CN¥9.77 and CN¥11.73.
Boai NKY Pharmaceuticals's market capitalization is CN¥6.8B. Its price-to-earnings (P/E) ratio is 46.9: you pay CN¥46.9 for each CN¥1.00 of yearly earnings.
Yes. 300109.SHE's current dividend yield is 1.43% at today's price (CN¥10.77).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy